HMS LINCS Batch ID,HMS LINCS ID,Name,Alternative Names,LINCS ID,Alternative ID,Reference Source,Organism,Organ,Tissue,Cell Type,Details of Cell Type,Donor Sex,Donor Age,Donor Ethnicity,Donor Health Status,Disease,Details of Disease,Production Details,Genetic Modification(s),Known Mutations,Citation Information for Mutations,Verification Reference Profile,Growth Properties,Recommended Culture Conditions,Relevant Citations,Usage Note,Comments,Provider,Provider Catalog ID,Provider Batch ID,Source Information,Date Received,HMS QC Outcome,Transient Modification(s),Date Publicly Available,Most Recent Update
50583-2,50583,MCF 10A,,LCL-2085,"CLO_0007599","ATCC CRL-10317",Homo sapiens,breast,,epithelial,,female,,,,fibrocystic disease,non-tumorigenic,,none,,,,adherent,,,,,Joe Gray (Oregon Health & Science University),MCF10A,,"Obtained by Joe Gray's group (Oregon Health & Science University) from ATCC before the establishment of the ICBP43 Collection and distributed in January, 2016, to HMS for comparative analysis as part of the LINCS MCF 10A Common Project",2016-01-29,PASS,,2012-11-02,2016-04-04
50583-4,50583,MCF 10A,,LCL-2085,"CLO_0007599","ATCC CRL-10317",Homo sapiens,breast,,epithelial,,female,,,,fibrocystic disease,non-tumorigenic,,none,,,,adherent,,,,,Gordon Mills (The University of Texas MD Anderson Cancer Center),MCF10A-ICBP43,,"Obtained by Gordon Mills' group (MD Anderson Cancer Center) from ATCC as part of the ICBP43 Collection and distributed in December, 2015, to all LINCS Centers for the LINCS MCF 10A Common Project",2015-12-01,PASS,,2012-11-02,2016-04-04
50583-9,50583,MCF 10A,,LCL-2085,"CLO_0007599","ATCC CRL-10317",Homo sapiens,breast,,epithelial,,female,,,,fibrocystic disease,non-tumorigenic,,none,,,,adherent,,,,,ATCC,CRL-10317,,"Obtained by Mario Niepel (Harvard Medical School) as part of the ICBP43 Collection in July, 2010",2010-07-16,PASS,,2012-11-02,2016-04-04
51124-1,51124,MCF 10A-H2B-mCherry,,,"CLO_0007599",Mario Niepel (Harvard Medical School),Homo sapiens,breast,,epithelial,,female,,,,fibrocystic disease,non-tumorigenic,"Modification type: retroviral transformation with an H2B-mCherry expression cassette that comprised AAVS1 homology arms, the hPGK promotor, and SV40 polyA terminator and integration into the AAVS1 safe harbor genomic locus using CRISPR/Cas9; followed by clonal selection based on transgene expression level. Citations: H2B-mCherry expression cassette: gift of Robert Benezra (Memorial Sloan Kettering Cancer Center), Addgene plasmid #20972; SV40 polyA terminator: gift from Rudolf Jaenisch (Whitehead Institute for Biomedical Research), Addgene plasmid # 22072.",H2B-mCherry integration at AAVS1 safe harbor locus,,,,adherent,,"PMID 27135972",,,Mario Niepel (Harvard Medical School),,,,,PASS,,2016-08-24,2016-08-24